Treatment Options for Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma (NHL) is a type of cancer that originates in the lymphatic system. It occurs when abnormal lymphocytes (a type of white blood cell) grow uncontrollably, leading to enlarged lymph nodes or tumors in other organs.

Treatment Options for Non-Hodgkin Lymphoma

Treatment strategies for NHL vary depending on the type, stage, and overall health of the patient. Common approaches include:

Surgery (Sx): Removal of tumors in localized cases.
Chemotherapy (ChemoRx): The mainstay of treatment for most NHL cases.
Targeted therapy + Chemotherapy: Combining targeted drugs with chemotherapy to enhance effectiveness.
Immunotherapy (ImmunoRx): Stimulating the immune system to fight cancer cells.
CAR T-cell therapy (CD19): Genetically modifying the patient’s T-cells to recognize and destroy cancer cells.
Stem Cell Transplantation: Resetting the bone marrow with healthy stem cells to rebuild the immune system and reduce recurrence.
Radiotherapy (XRT): Often used for bulky masses or localized disease.

Treatment Pathway

NHL treatment often starts with Induction therapy to induce remission. If patients achieve Complete Remission (CR), doctors may proceed with Consolidation therapy to prevent relapse.

For patients with resistant or relapsed disease, options may include high-dose chemotherapy, stem cell transplantation, or radiotherapy.

The treatment of Non-Hodgkin Lymphoma combines standard approaches (surgery, chemotherapy, radiotherapy) with modern innovations (targeted therapy, immunotherapy, CAR T-cell, and stem cell transplantation).

Each treatment plan must be tailored to the individual to maximize effectiveness and minimize side effects.